(1)
Thaçi, D.; Vender, R.; de Rie, M.; Conrad, C.; Soung, J.; Strober, B.; Wang, M.; Cross, N.; Deherder, D.; Gomez, N. N.; Gottlieb, A. B. Bimekizumab Efficacy and Safety through Three Years in Patients With Moderate to Severe Plaque Psoriasis: Long-Term Results from the BE SURE Randomized Controlled Trial and the BE BRIGHT Open-Label Extension. J of Skin 2022, 6, s68.